Akari Therapeutics Plc (AKTX)
3.70
+0.16
(+4.52%)
USD |
NASDAQ |
Apr 07, 16:00
3.30
-0.40
(-10.81%)
After-Hours: 20:00
Akari Therapeutics Total Assets (Quarterly) : 48.00M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 233.72M |
| Cellectis SA | 331.48M |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 45.92M |
| Bicycle Therapeutics Plc | 717.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.67M |
| Shareholders Equity (Quarterly) | 28.33M |
| Debt to Equity Ratio | 0.0266 |
| Current Ratio | 0.4422 |
| Net Debt Paydown Yield | 0.68% |